Cargando…
Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes
BACKGROUND: Partial gland ablation (PGA) is a new option for treatment of prostate cancer (PCa). Cryotherapy, an early method of PGA, has had favorable evaluations, but few studies have employed a strict protocol using biopsy endpoints in men with clinically significant prostate cancer (csPCa). METH...
Autores principales: | Aker, Mamdouh N., Brisbane, Wayne G., Kwan, Lorna, Gonzalez, Samantha, Priester, Alan M., Kinnaird, Adam, Delfin, Merdie K., Felker, Ely, Sisk, Anthony E., Kuppermann, David, Marks, Leonard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166973/ https://www.ncbi.nlm.nih.gov/pubmed/36775929 http://dx.doi.org/10.1002/cam4.5692 |
Ejemplares similares
-
Magnetic Resonance Imaging–Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
por: Jayadevan, Rajiv, et al.
Publicado: (2019) -
Commentary: Cryotherapy and the sebaceous glands
por: Mehta, Aditi, et al.
Publicado: (2022) -
Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging
por: Topoozian, Mark, et al.
Publicado: (2023) -
Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes
por: Qaoud, Yazan, et al.
Publicado: (2020) -
Cryotherapy for removal of an embedded, partially covered esophageal stent
por: Deep, Aman, et al.
Publicado: (2022)